Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and Neck

Clinical trial NCT01998542 · COMPLETED

Trial details

NCT number: NCT01998542
Sponsor: Mirror Biologics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cancer of Head and Neck Squamous Cell Carcinoma of the Head and Neck

Start date: 2016-01-01
Primary completion: 2017-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.